CliniGA CRO

CliniGA Clinical Research

CliniGA CRO — Clinical research. Clearly coordinated.

CliniGACRO.com is the official website of CliniGA CRO, supporting pharma, biotech and medical device sponsors in Türkiye and worldwide.

Who CliniGA CRO supports

CliniGA connects clinical operations, regulatory strategy, sites, data and medical device evidence across Türkiye and international markets.

  • Pharmaceutical, biotechnology and health technology organizations: Phase I–IV, observational, real-world and digital evidence programmes.
  • Medical device manufacturers: EU MDR clinical evidence, investigations and post-market clinical follow-up.
  • Hospitals, research centers and investigator networks: protocol operations, site coordination and study conduct support.

Clinical research organization services

Sponsors can engage CliniGA CRO for a focused work package or an integrated delivery model covering feasibility, start-up, conduct and close-out.

  • Clinical operations and monitoring: feasibility, study start-up, site selection, on-site and centralised monitoring, and project management under ICH-GCP.
  • SMO and site coordinator support: site identification, coordinator resourcing and site-level quality oversight in Türkiye, scaled per study after feasibility.
  • Regulatory affairs: submission dossiers, ethics and authority planning, amendments and lifecycle maintenance for Türkiye and European programmes.
  • Medical device clinical evidence: EU MDR 2017/745 clinical evaluation planning, ISO 14155-aligned investigations, PMCF strategy and technical documentation input.
  • Quality systems and compliance: risk-based quality management, SOP frameworks, deviation and CAPA handling, audit and inspection readiness.
  • Data, biostatistics and medical writing: data management, statistical planning, clinical study reporting and publication support with documented human review.
  • Site network and feasibility: protocol-led site selection, evidence-based recruitment assumptions and operational readiness assessment across qualified sites and partners.
  • Clinical technology and sample integrity: cold-chain monitoring, chain of custody, equipment lifecycle control and operations reporting, qualified and piloted per project.

Evidence-led delivery

CliniGA states assumptions rather than promises, applies quality-by-design and proportionate oversight, and requires human review before a deliverable reaches a sponsor.

  • Scope, responsibilities, decisions and escalation routes are documented before work starts.
  • Sites, timelines and recruitment assumptions are tested during feasibility before they enter a plan.
  • Privacy and security are designed around GDPR and KVKK principles.
  • Türkiye, Europe including Central and Eastern Europe, and the Middle East are supported subject to country-specific feasibility and contracting.